NCT05600504

Brief Summary

Anxiety and depression in later life are highly prevalent, often appear as comorbid disorders, and have many adverse consequences for both the individual and society. Given the disease burden, the large influx of new cases, and the economic costs, efforts should be made to prevent the onset of anxiety and depression in later life. Preventive interventions are likely to become more cost effective when they are targeted at elderly who have been exposed to risk factors known to be predictive of the onset of anxiety and/or depression. As the population aging is speeding up, senile diseases have become a significant and severe public health problem, influencing national health. More than 20 million elderly patients undergo surgery each year in China, accounting for a quarter of the population who undergo surgery. Therefore, it is necessary to construct a predictive model of anxiety and depression in perioperative elderly hospitalized patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,386

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 31, 2022

Completed
Last Updated

July 16, 2024

Status Verified

July 1, 2024

Enrollment Period

1.6 years

First QC Date

October 27, 2022

Last Update Submit

July 15, 2024

Conditions

Keywords

predicted modeldepressionanxietyelderly patient

Outcome Measures

Primary Outcomes (1)

  • Depression

    Primary outcomes were depression Patient Health Questionnaire 9 (PHQ-9).The PHQ-9 is a nine-item questionnaire for screening on the presence of depressive symptoms and monitoring depression severity. Items were scored on a four-point scale with total scores ranging from zero to twenty-seven. Scores were defined as: ≥5 mild, ≥10 moderate, and ≥15 severe level of depression. The recommended screening cutoff was ≥10, corresponding with at least a moderate level of depression. The higher the score, the worse the situation. The total score ranges from 0 to 27, and higher scores indicate more depressive symptoms.

    Depression within 7 days of surgery

Secondary Outcomes (1)

  • Anxiety

    Anxiety within 7 days of surgery

Study Arms (2)

No depression

no intervention

Other: no intervention

Depression

no intervention

Other: no intervention

Interventions

no intervention

DepressionNo depression

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elderly patients, aged 65 years and above, who underwent elective non-cardiac surgeries in China during the period spanning from April 1, 2020, to April 30, 2022.

You may qualify if:

  • elective non-cardiac surgery,
  • American society of Aneshesiologists (ASA) classification Ⅰ \~ Ⅲ,
  • patients over age 65.

You may not qualify if:

  • patient refused follow-up study,
  • missing data exceeding 20%,
  • went to ICU or died after surgery,
  • have a history of any mental disorders such as epilepsy, Parkinson's disease, depression, anxiety, sleep disorders, or are currently taking relevant intervention drugs 5) patients with severe deafness, dementia or speech impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Weidong Mi, PhD

    Chinese PLA General Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director (Cheif expert of National key research and development program of China 2018YFC2001900)

Study Record Dates

First Submitted

October 27, 2022

First Posted

October 31, 2022

Study Start

April 1, 2020

Primary Completion

October 31, 2021

Study Completion

April 30, 2022

Last Updated

July 16, 2024

Record last verified: 2024-07

Locations